I think that some of the cons include shares on issue, liabilities for licensing, and also becoming irrelevant based on another firms progress. Over 700 oncology biotechs on registries. This is a good race horse, the pipeline potential and leadership is top notch. I hold a fair amount for a penny stock. 10K USD worth, I’m gambling fairly hard on it but understand the risk.
IMU: investment pros and cons, page-5
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.002(4.35%) |
Mkt cap ! $349.6M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.8¢ | 4.6¢ | $425.4K | 9.074M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2679863 | 4.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.8¢ | 4279405 | 24 |
View Market Depth
| Last trade - 12.56pm 11/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |